SALIVARY GLAND CANCER STAGE IV

SALIVARY GLAND CANCER STAGE IV was reported 15 times

SALIVARY GLAND CANCER STAGE IV is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nonergot Dopamine Agonist [EPC] 5 0.0003
1 Topoisomerase Inhibitor [EPC] 5 0.0001
2 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
3 Loop Diuretic [EPC] 6 0.0000
4 Platinum-based Drug [EPC] 3 0.0000
5 Kinase Inhibitor [EPC] 4 0.0000
6 Proton Pump Inhibitor [EPC] 4 0.0000
7 Azole Antifungal [EPC] 1 0.0000
8 Interferon beta [EPC] 1 0.0000
9 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
10 Thalidomide Analog [EPC] 1 0.0000